USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: GERINDA THERAPEUTICS, INC
City: CARY
State: NC
Zip+4: 27513-2012
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $248,481.00 1

Award List:

New ultra-selective kinase inhibitors for the treatment of AML

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Magnus P. Pfahl – 858-646-0706
Award Amount: $248,481.00
Abstract:
DESCRIPTION (provided by applicant): Acute Myeloid Leukemia (AML) accounts for a high percentage of all adult leukemia cases. Although most patients at first respond well to conventional chemotherapy, there is a high rate of relapse and patients become refractory to front-line treatment, which bears… More